Sygnature Accelerates Customers’ Drug Discovery Timelines with Improved Hit Identification, Lead Optimization Capabilities
SANTA FE, N.M., USA, & NOTTINGHAM, UK – 21 January 2021 – OpenEye Scientific and Sygnature Discovery – a world-leading integrated discovery and pre-clinical solutions provider – today announced the adoption of OpenEye’s Orion™ platform to power Sygnature’s computational efforts in molecular design drug discovery solutions.
Read More
OpenEye Scientific is pleased to announce the release of OpenEye Applications and Toolkits 2020.2, which contains several key upgrades and improved performance.
Read MoreAs your team engages in molecular design, you likely are working in a number of disparate applications. As a result, you and your team may have challenges organizing, annotating, or sharing your the data from those applications.
Read More
OpenEye Scientific Helps Beacon Discovery Increase Speed and Improve Activity in Virtual Screening
Read More
OpenEye Scientific is pleased to announce the release of Orion v2020.2 Update.
Orion’s new features will provide more flexibility and speed to your molecular design processes, including the ability to:
SANTA FE, N.M., & NEW YORK, N.Y. – July 30, 2020 – OpenEye Scientific (OpenEye) and CHDI Foundation (CHDI) today announced a research collaboration to identify novel small-molecule therapeutics for Huntington’s disease (HD) utilizing Orion, OpenEye’s cloud-native molecular design platform.
Read More
OpenEye Scientific is pleased to announce the release of OpenEye Applications v2020.0 and OpenEye Toolkits v2020.0, with several key updates and improved features to increase speed and functionality for molecular design. These packages include the usual support for Linux, macOS, and Windows. In addition, the toolkit libraries include the usual support for C++, C#, Java, and Python.
High performance libraries provide strong foundation for new developments to StarDrop drug discovery software.
CAMBRIDGE, UK and SANTA FE, NEW MEXICO, USA: 12 April, 2020 – Optibrium™ and OpenEye Scientific (OpenEye), leading providers of software and services for drug discovery, today announced that StarDrop™, Optibrium’s software for small molecule design, optimisation and data analysis, is now powered by OpenEye Scientific’s cheminformatics toolkits.
Read More
Partnership will advance both firms' positions in the field of molecular dynamics-based drug discovery
New York City & Santa Fe – December 4, 2019 - Redesign Science and OpenEye Scientific are pleased to announce that they have entered into a strategic partnership to integrate OpenEye's pioneering Orion computational platform into Redesign's drug discovery platform.
Read More
